Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.
30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00
52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,961 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,59,66358.6% delivered
Lupin orders, deals and press releases
1,075 filed, newest first. Page 21 of 22.
Jul 2010
Jun 2010
8 Jun · Business
Allotment Committee of Directors at its meeting held on June 08, 2010 has allotted 15414 fully paid up equity shares of Rs. 10/- each. These shares have been allotted upon exercising of options granted to the employees under Stock Option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 889,998,190 consisting 88,999,819 equity shares of Rs. 10/- each.
May 2010
28 May · Business
Hon'ble Bombay High Court sanctioned the scheme of amalgamation of Lupin Pharmacare Limited and Lupin Herbal Limited (Transferor Companies), wholly-owned subsidiaries of Lupin Limited, with Lupin Limited (Transferee Company) w.e.f. April 1, 2009 ("Appointed Date"). The Hon'ble High Court of Gujarat at Ahmedabad also sanctioned the scheme of amalgamation of Novodigm Limited (Transferor Company), another wholly-owned subsidiary of Lupin Limited, with Lupin Limited (Transferee Company) w.e.f. April 1,2009 ("Appointed Date). Further, the Court Orders have been filed with the Registrar of Companies.14 May · Business
Allotment Committee of Directors at its meeting held on May 14, 2010 has allotted 13855 fully paid up equity shares of Rs. 10 each. These shares have been allotted upon exercising of options granted to the employees under Stock Option plans of the Company. In view of the above, the issued and paid up capital of the company has been increased to Rs. 889,844,050 consisting 88,984,405 equity shares of Rs. 10 each.
Apr 2010
20 Apr · Business
Press release dated April 20, 2010, titled " Lupin receives FDA approval for Imipramine Pamoate Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2010
25 Mar · Business
Press release dated March 25, 2010, titled " Lupin launches Hyalgan in India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Mar · Business
Press release dated March 20, 2010, titled "Lupin receives FDA tentative approval for Eszopiclone tablets". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
8 Feb · Business
Press release dated February 08, 2010, titled "Lupin receives US FDA approval for Amlodipine / Benazepril capsules". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
29 Jan · Business
Vide its letter dated January 29, 2010 regarding a press release dated January 28, 2010 titled "Lupin Strengthens its Board; Appoints Three Independent Directors". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jan · Business
Press release dated January 29, 2010, titled "Lupin Net Profit up 38% - Q3 FY 2009-10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Jan · Business
Press release dated January 28, 2010, titled "Lupin receives US FDA approval for Perindopril Erbumine Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jan · Business
Press release dated January 20, 2010, titled "Lupin receives US FDA tentative approval for Memantine HC1 tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jan · Business
Press release dated January 20, 2010, titled "US FDA clears Lupin's Mandideep Facility". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
22 Dec · Business
Press release dated December 22, 2009, titled " Lupin Announces Litigation Settlement with Forest for Memantine Tablets." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
26 Oct · Business
Press release dated October 26, 2009, titled "Lupin Q2 Net Profit up 39%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Oct · Business
Press release dated October 05, 2009, titled "Lupin Licenses US Rights for Proprietary Bioadhesive Technology for Rifaximin to Salix Pharmaceuticals". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
29 Sep · Business
Press release dated September 28, 2009, titled "Lupin Expands Branded Play Announces Acquisition of US Rights to ANTARA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
29 Jul · Business
Press release dated July 29, 2009, titled "Lupin Net Profit up by 25% in Q1, FY 2009-10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
30 Jun · Business
Press release dated June 30, 2009, titled "Lupin Expands Branded Play; Announces Acquisition of Worldwide Rights for its first NDA - AllerNaze". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
13 May · Business
Press release dated May 13, 2009, titled "Lupin FY 2008-09 Consolidated Net Profits up 50.2% to Rs 5015 mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 May · Business
Press release dated May 11, 2009, titled "Lupin announces Litigation Settlement with Wyeth for Venlafaxine Extended Release Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
9 Apr · Business
Press release dated April 09, 2009, titled "Lupin in alliance with Natco; Alliance to commercialize generic equivalent of FOSRENOL(R) Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2009
26 Mar · Business
Press release dated March 26, 2009, titled "Lupin in Equity Partnership with Multicare Pharmaceuticals Philippines, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Mar · Business
Press release dated March 09, 2009, titled "Lupin ties up with leading Institutes for PhD Program". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
29 Jan · Business
Press release dated January 29, 2009 titled "Lupin Q3 FY 08-09 - Strong Growth & Consistent Performance; Consolidated Sales up 32% to Rs.9719 Mn, Net Profit - Rs 1165 Mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jan · Business
Press release dated January 16, 2009, titled "Lupin receives USFDA approval for Levetiracetam Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2008
17 Dec · Business
Press release dated December 17, 2008, titled "Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Dec · Business
Press release dated December 12, 2008, titled "Lupin appoints Divakar Kaza as President- Human Resources". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
14 Nov · Business
Press release dated November 13, 2008 , titled "Lupin announces results of US FDA Inspection ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
24 Oct · Business
Press release dated October 24, 2008 titled " Lupin Q2 FY 08-09 - Strong Performance & Strategic Growth - Consolidated Net Profit up 53% to Rs.1156 Mn, Sales at Rs 9221 Mn up by 36%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
18 Sep · Business
Press release dated September 18, 2008, titled " Lupin in Equity Partnership with Pharma Dynamics, South Africa". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
21 Aug · Business
Press release dated August 21, 2008, titled "Lupin Acquires Stake in Generic Health, Australia ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Aug · Business
Press release dated August 19, 2008, titled "Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc for AeroChamber Plus(R) Brand in the US ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
31 Jul · Business
Press release dated July 31, 2008, titled "Lupin receives USFDA approval for Divalproex Sodium Delayed-Release Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jul · Business
Press release dated July 30, 2008, titled "Lupin Makes an Acquisition in Germany". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jul · Business
Press release dated July 22, 2008, titled "Lupin Q1, FY08-09 Consolidated Net Profit up 101% to Rs.1120 Mn, Sales at Rs 8792 Mn up by 49%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
26 Jun · Business
Press release dated June 26, 2008, titled "Lupin appoints New NCE Research Head". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Jun · Business
Press release dated June 23, 2008, titled "Lupin Enters Into Marketing Alliance with Ascend Therapeutics for SUPRAX(R) 400mg Tablets in the U.S.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jun · Business
Press release dated June 16, 2008, titled "Lupin receives USFDA approval for Escitalopram Oxalate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jun · Business
Press release dated June 11, 2008, titled "Lupin launches Ramipril capsules in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
30 May · Business
Press release dated May 30, 2008, titled "Lupin receives USFDA Approval for Topiramate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 May · Business
Press release dated May 14, 2008, titled "Lupin FY 2007-08 Consolidated Net Profit up 32% to Rs.4083 mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
28 Apr · Business
Press release dated April 28, 2008, titled "Lupin Launches SUPRAX 400 mg Tablets in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Apr · Business
Press release dated April 23, 2008, titled "Lupin expands its product basket in Japan; Kyowa receives Ten product approvals". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
22 Jan · Business
Press release dated January 22, 2008, titled "Lupin Q3 FY0708 Consolidated Net Profit up 192% to Rs. 1809 Mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
14 Nov · Business
Press release dated November 13, 2007, titled "Lupin gets new Pharmaceutical Research Head". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
24 Oct · Business
Press release dated October 24, 2007, titled "Lupin FY 2007-08 Q2 Consolidated Net Profit up 46% to Rs. 756 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Oct · Business
Press release dated October 12, 2007, titled "Lupin sells additional Perindopril patents to Servier". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.